A&Es ‘swamped’ with patients over fears of AstraZeneca blood clots
Emergency doctors report ‘huge numbers’ of patients concerned about headaches after jab
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Patients worried about blood clots after having the AstraZeneca vaccine are swamping hospital A&E departments, doctors have warned.
After new evidence of an emerging link between the vaccine and very rare blood clots, emergency departments across England have reported a surge in patients worried they may be affected.
A&E clinicians quoted in the Health Service Journal said their departments were “swamped” with patients attending with headaches and said some had been sent their by local GPs.
On Thursday UK regulator the Medicines and Healthcare products Regulatory Agency (MHRA) said anyone who reported a severe or persistent headache that did not respond to painkillers, four days after receiving the vaccine, should speak to their doctor.
Other symptoms to watch out for include a shortness of breath, chest or persistent abdominal pain, leg swelling, blurred vision, seizures or unexplained pin prick rash or bruising away from the injection site.
The potential side effect, known as thrombocytopaenia, is extremely rare, with only 79 cases identified where a blood clot developed among AstraZeneca recipients. This suggests only one in 250,000 who receive the jab will develop it.
One A&E consultant said: “We have seen huge numbers of AstraZeneca jab-associated headaches being sent in and, like all [emergency departments], we’re scrabbling to cobble together some guidance so as to sensibly reduce the number needing investigation. I gather some units are really, really struggling with this.”
Katherine Henderson, president of the Royal College of Emergency Medicine told The Guardian the problem was being reported across the country.
She said: “It’s definitely a thing. Colleagues across England are reporting this. All A&E departments are seeing an increase in the number of people reporting concerns after having the AstraZeneca vaccine. We are seeing people with mild headaches and persistent headaches but who are otherwise alright.
“Emergency departments and GPs are getting a lot of queries. I think it’s an understandable reaction by the public. I can understand why people are anxious. If they are worried they need to get advice.”
An NHS England spokesperson said: “The NHS will continue to offer a vaccine that is right for the individual. As the MHRA and JCVI have said, serious side effects are extremely rare and PHE has issued updated advice on when individuals should seek urgent medical advice.”
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments